North America Bispecific Antibodies Market Size, Share & Industry Trends Analysis Report By Indication (Cancer, Inflammatory & Autoimmune Disorder and Others), By Country and Growth Forecast, 2023 - 2030

TABLE 1 North America Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 2 North America Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Bispecific Antibodies Market
TABLE 4 Trials and Approvals – Bispecific Antibodies Market
TABLE 5 Acquisition and Mergers– Bispecific Antibodies Market
TABLE 6 North America Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 7 North America Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 8 North America Cancer Market by Country, 2019 - 2022, USD Million
TABLE 9 North America Cancer Market by Country, 2023 - 2030, USD Million
TABLE 10 North America Inflammatory & Autoimmune Disorder Market by Country, 2019 - 2022, USD Million
TABLE 11 North America Inflammatory & Autoimmune Disorder Market by Country, 2023 - 2030, USD Million
TABLE 12 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 13 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 14 North America Bispecific Antibodies Market by Country, 2019 - 2022, USD Million
TABLE 15 North America Bispecific Antibodies Market by Country, 2023 - 2030, USD Million
TABLE 16 US Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 17 US Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 18 US Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 19 US Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 20 Canada Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 21 Canada Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 22 Canada Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 23 Canada Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 24 Mexico Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 25 Mexico Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 26 Mexico Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 27 Mexico Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 28 Rest of North America Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 29 Rest of North America Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 30 Rest of North America Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 31 Rest of North America Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 32 Key Information – Amgen, Inc.
TABLE 33 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 34 Key Information – Pfizer, Inc.
TABLE 35 Key Information – Akeso, Inc.
TABLE 36 Key information –Johnson & Johnson
TABLE 37 key Information – Taisho Pharmaceuticals Holding Co., Ltd.
TABLE 38 Key Information – Immunocore Holdings plc
TABLE 39 Key Information – GlaxoSmithKline PLC
TABLE 40 Key Information – Novartis AG
TABLE 41 Key Information – Allergan PLC

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 4 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2020, Jun – 2022, Dec) Leading Players
FIG 5 North America Bispecific Antibodies Market share by Indication, 2022
FIG 6 North America Bispecific Antibodies Market share by Indication, 2030
FIG 7 North America Bispecific Antibodies Market by Indication, 2019 - 2030, USD Million
FIG 8 North America Bispecific Antibodies Market share by Country, 2022
FIG 9 North America Bispecific Antibodies Market share by Country, 2030
FIG 10 North America Bispecific Antibodies Market by Country, 2019 - 2030, USD Million
FIG 11 Recent strategies and developments: Johnson & Johnson